Tocilizumab and Anakinra for Cytokine Storm
Jun 09, 2021
Scientists consider whether anti-cytokine therapies tocilizumab and anakinra might alleviate disease severity in COVID 19. Tocilizumab (an IL-6 blocker) has been tested with possible benefit. These results have been mixed. Anakinra (an anti-IL-1 medication) as also tested with mixed results. These drugs have been used for macrophage activation syndrome with some success.
Original Article:
Ryo Otsuka, Ken-ichiro Seino. Macrophage activation syndrome and COVID-19. Inflammation and Regeneration, 2020; 40 (1) DOI: 10.1186/s41232-020-00131-w
Thanks to Science Daily:
Hokkaido University. “Cellular-level interactions that lead to the cytokine storm in COVID-19.” ScienceDaily. ScienceDaily, 8 September 2020. <www.sciencedaily.com/releases/2020/09/200908122534.htm>.
What is your Immune System telling you?
What have we learned in the past couple of years, especially since the outbreak of a global pandemic?
Your Immune System CAN'T be ignored!
NOW is the time to prep your immune system...because we face a myriad of viruses, bacteria, mold, and toxins EVERY DAY! Only a strong immune system will truly combat these potential threats.
Take the Immunity Quiz today to see how YOUR immune system ranks and how prepared you truly are!
Free Online Program:
Natural Allergy Therapies
Stop letting Allergies slow you down! Follow Dr. Eric Potter's proven strategies for reducing or eliminating Allergies.
We hate SPAM. We will never sell your information, for any reason.
